seen from United States
seen from South Korea
seen from Spain
seen from China
seen from United States
seen from China
seen from United States
seen from Canada
seen from China
seen from United States
seen from Germany
seen from United Kingdom
seen from Philippines
seen from Egypt
seen from United States
seen from Japan
seen from Russia
seen from South Korea
seen from United Kingdom
seen from United States
Positive trans captions
O'Connor has been very receptive to the Trump admin and its anti-trans efforts, but an FTC request to him is now on hold after "consultation
Chris Geidner at Law Dork:
The Trump administration apparently found a way to go so far afield of appropriate litigation tactics that even U.S. District Judge Reed O’Connor has agreed to put a case before him on hold. In a late-night filing on Thursday, Federal Trade Commission lawyers, joined by lawyers from Texas and Iowa, asked O’Connor to issue an extraordinary and manipulative order in the FTC’s lawsuit targeting the World Professional Association for Transgender Health, Inc. (WPATH) for what they claim are its “deceptive practices” regarding the provision of gender-affirming care for minors. The Thursday night request sought an order from O’Connor — a far-right George W. Bush appointee in the Northern District of Texas — barring WPATH from “seeking relief in this matter from courts other than this Court, the United States Court of Appeals for the Fifth Circuit, and the United States Supreme Court.“ It was a blatant effort to make an end-run around another court and another case involving WPATH and the FTC, before U.S. District Judge James Boasberg in Washington, D.C. By Friday afternoon, however, O’Connor announced that his consideration of the FTC’s request was on hold following “consultation” that O’Connor held with Boasberg.
What is going on?
O’Connor issued a similar order earlier this year to the one requested by the FTC on Thursday, in conjunction with the challenge to DOJ’s administrative subpoena issued against Rhode Island Hospital. There, the order was absurd, but it did at least follow a factual scenario — as bad as it was — where the initial litigation in the case about the Rhode Island hospital was in Texas. This time, however, WPATH had filed its own lawsuit against the FTC in February. The case was filed in D.C. — where the FTC is headquartered — and the case was assigned Boasberg, an Obama appointee. The FTC’s lawsuit, on the other hand, wasn’t filed in the Northern District of Texas until June 17 — more than a month after Boasberg had issued a preliminary injunction and associated opinion in the WPATH-brought case. Because of that, on June 30, WPATH filed a motion (and memorandum of law) before Boasberg seeking to block the FTC “from litigating the claims asserted in FTC v. WPATH, 4:26-cv-748-O (N.D. Tex.), except as mandatory counterclaims brought before this Court.“ As part of that filing, in discussing other grand jury subpoenas issued relating to gender-affirming care, one of WPATH’s lawyers acknowledged that one of its members had received a grand jury subpoena out of the Northern District of Texas on June 16 — the day before the filing of the FTC’s lawsuit there but still well after the initial injunction in the case before Boasberg. Following that June 30 filing, the parties conferred and submitted a proposed briefing schedule, which Boasberg approved on Thursday.
The Trump Regime’s request in FTC v. WPATH has been put on hold by far-right judicial activist Reed O’Connor, who nearly always grants the Trump Regime nearly everything they ask.
See Also:
The Advocate: Trump officials were so extreme in transgender health case that a Texas judge hit pause
Two sentences into chapter 2 of WPATH SoC 8.
I''m gonna be haunted by this shit till the day I fucking die.
Another random bus inspired meme
Court documents offer a window into how this happens
By: Jesse Singal
Published: Jun 27, 2024
In April Hilary Cass, a British paediatrician, published her review of gender-identity services for children and young people, commissioned by NHS England. It cast doubt on the evidence base for youth gender medicine. This prompted the World Professional Association for Transgender Health (WPATH), the leading professional organisation for the doctors and practitioners who provide services to trans people, to release a blistering rejoinder. WPATH said that its own guidelines were sturdier, in part because they were “based on far more systematic reviews”.
Systematic reviews should evaluate the evidence for a given medical question in a careful, rigorous manner. Such efforts are particularly important at the moment, given the feverish state of the American debate on youth gender medicine, which is soon to culminate in a Supreme Court case challenging a ban in Tennessee. The case turns, in part, on questions of evidence and expert authority.
Court documents recently released as part of the discovery process in a case involving youth gender medicine in Alabama reveal that WPATH's claim was built on shaky foundations. The documents show that the organisation’s leaders interfered with the production of systematic reviews that it had commissioned from the Johns Hopkins University Evidence-Based Practice Centre (EPC) in 2018.
From early on in the contract negotiations, WPATH expressed a desire to control the results of the Hopkins team’s work. In December 2017, for example, Donna Kelly, an executive director at PATH, told Karen Robinson, the EPC's director, that the WPATH board felt the EPC researchers “cannot publish their findings independently”. A couple of weeks later, Ms Kelly emphasised that, “the [WPATH] board wants it to be clear that the data cannot be used without WPATH approval”.
Ms Robinson saw this as an attempt to exert undue influence over what was supposed to be an independent process. John Ioannidis of Stanford University, who co-authored guidelines for systematic reviews, says that if sponsors interfere or are allowed to veto results, this can lead to either biased summaries or suppression of unfavourable evidence. Ms Robinson sought to avoid such an outcome. “In general, my understanding is that the university will not sign off on a contract that allows a sponsor to stop an academic publication,” she wrote to Ms Kelly.
Months later, with the issue still apparently unresolved, Ms Robinson adopted a sterner tone. She noted in an email in March 2018 that, “Hopkins as an academic institution, and I as a faculty member therein, will not sign something that limits academic freedom in this manner,” nor “language that goes against current standards in systematic reviews and in guideline development”.
Not to reason XY
Eventually WPATH relented, and in May 2018 Ms Robinson signed a contract granting WPATH power to review and offer feedback on her team’s work, but not to meddle in any substantive way. After WPATH leaders saw two manuscripts submitted for review in July 2020, however, the parties’ disagreements flared up again. In August the WPATH executive committee wrote to Ms Robinson that WPATH had “many concerns” about these papers, and that it was implementing a new policy in which WPATH would have authority to influence the EPC team’s output—including the power to nip papers in the bud on the basis of their conclusions.
Ms Robinson protested that the new policy did not reflect the contract she had signed and violated basic principles of unfettered scientific inquiry she had emphasised repeatedly in her dealings with WPATH. The Hopkins team published only one paper after WPATH implemented its new policy: a 2021 meta-analysis on the effects of hormone therapy on transgender people. Among the recently released court documents is a WPATH checklist confirming that an individual from WPATH was involved “in the design, drafting of the article and final approval of [that] article”. (The article itself explicitly claims the opposite.) Now, more than six years after signing the agreement, the EPC team does not appear to have published anything else, despite having provided WPATH with the material for six systematic reviews, according to the documents.
No one at WPATH or Johns Hopkins has responded to multiple inquiries, so there are still gaps in this timeline. But an email in October 2020 from WPATH figures, including its incoming president at the time, Walter Bouman, to the working group on guidelines, made clear what sort of science WPATH did (and did not) want published. Research must be “thoroughly scrutinised and reviewed to ensure that publication does not negatively affect the provision of transgender health care in the broadest sense,” it stated. Mr Bouman and one other coauthor of that email have been named to a World Health Organisation advisory board tasked with developing best practices for transgender medicine.
Another document recently unsealed shows that Rachel Levine, a transwoman who is assistant secretary for health, succeeded in pressing WPATH to remove minimum ages for the treatment of children from its 2022 standards of care. Dr Levine’s office has not commented. Questions remain unanswered, but none of this helps WPATH’s claim to be an organisation that bases its recommendations on science.
[ Via: https://archive.today/wJCI7 ]
--
==
So, there are 6 completed reviews sitting somewhere, that WPATH knows shows undesirable (to them) results. And they know it. And despite - or perhaps, because of - that, they wrote the insane SOC8 anyway. And then, at the behest of Rachel Levine, went back and took out the age limits, making it even more insane.
This isn't how science works, it's how a cult works.
When John Templeton Foundation commissioned a study on the efficacy of intercessory prayer, a study which unsurprisingly found that it's completely ineffective, it was forced to publish the negative results.
So, even the religious are more ethical than gender ideologues when it comes to science. This is outright scientific corruption.
The Federal Trade Commission, along with Alaska, Iowa, Nebraska and Texas, today filed a lawsuit against the World Professional Association
Heads up, gang.
"A senior doctor at the facility co-authored WPATH's "Standards of Care," and the facility has received more than $100 million from HHS throughout its history" 😒
How pro-trans of them!
